Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma

被引:0
|
作者
Yukio Chiba
Tetsuro Taniguchi
Katsuhiko Matsuyama
Masato Sasaki
Yasushi Kato
Hirokazu Tanaka
Ryusuke Muraoka
Nobuhiko Tanigawa
机构
[1] Fukui Medical University,Second Department of Surgery
来源
Surgery Today | 1999年 / 29卷
关键词
angiogenesis; p53; apoptosis; lung adenocarcinoma; hematogenous metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to clarify which factors are important as predictors not only of patient survival but also of hematogenic metastasis in 15 patients with stage I lung adenocarcinoma who underwent curative operation. The relationship between tumor angiogenesis, apoptosis, and p53 oncogene was also studied. A total of 15 patients were divided into two groups: surviving group (n=7) and nonsurviving (metastasis) group (n=8). We studied the medical charts, operative records, pathologic reports, and tumor specimens taken at surgical resection. We measured the apoptotic index using the ApopTag kit and the intratumoral microvessel count using an anti-CD34 monoclonal antibody. In addition, immunohistochemical staining for the expression of p53 was conducted simultaneously. The clinicopathological characteristics, including age, sex, tumor size (pT), and histological differentiation, were not significantly different between the surviving and the nonsurviving group. The microvessel count was significantly higher in nonsurviving group than in the surviving group. The apoptotic index and the expression of p53 was not significantly different between the two groups. An inverse correlation between the apoptotic index and microvessel count, and a positive correlation between the expression of p53 and microvessel count, were observed. Angiogenesis may be an important prognostic factor in patients with stage I lung adenocarcinoma.
引用
收藏
页码:1148 / 1153
页数:5
相关论文
共 50 条
  • [21] Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung
    Minami, K
    Saito, Y
    Imamura, H
    Okamura, A
    LUNG CANCER, 2002, 38 (01) : 51 - 57
  • [22] P53 overexpression in advanced-stage endometrial adenocarcinoma
    Kohler, MF
    Carney, P
    Dodge, R
    Soper, JT
    ClarkePearson, DL
    Marks, JR
    Berchuck, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (05) : 1246 - 1252
  • [23] p53 and apoptosis
    Gottlieb, TM
    Oren, M
    SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) : 359 - 368
  • [24] p53 takes on angiogenesis
    Schubert, Charlotte
    NATURE MEDICINE, 2006, 12 (09) : 1003 - 1003
  • [25] p53 and apoptosis
    Bellamy, COC
    BRITISH MEDICAL BULLETIN, 1997, 53 (03) : 522 - 538
  • [26] Leveraging a p53 "super-tumor suppressor" to understand mechanisms of lung adenocarcinoma regression
    Wang, Mengxiong
    Kaiser, Alyssa
    Bieging-Rolett, Kathryn
    Brady, Colleen
    Attardi, Laura
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Analysis of stage I lung carcinoma patients including p53 and Rb protein
    Goldstein, NS
    ANNALS OF THORACIC SURGERY, 2000, 69 (05): : 1648 - 1648
  • [28] Policing of oncogene activity by p53
    Alejo Efeyan
    Isabel Garcia-Cao
    Daniel Herranz
    Susana Velasco-Miguel
    Manuel Serrano
    Nature, 2006, 443 : 159 - 159
  • [29] Policing of oncogene activity by p53
    Efeyan, Alejo
    Garcia-Cao, Isabel
    Herranz, Daniel
    Velasco-Miguel, Susana
    Serrano, Manuel
    NATURE, 2006, 443 (7108) : 159 - 159
  • [30] Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
    Chou, Cheng-Wei
    Lin, Ching-Heng
    Hsiao, Tzu-Hung
    Lo, Chia-Chien
    Hsieh, Chih-Ying
    Huang, Cheng-Chung
    Sher, Yuh-Pyng
    SCIENTIFIC REPORTS, 2019, 9 (1)